Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard H van den Berg

Showing results (1-10 of 559) with videos related to

Pageof 56
Sort By:
The Lancet. Neurology|October 10, 2014
Therapy of amyotrophic lateral sclerosis remains a challengeLeonard H van den Berg
Journal of Neurology, Neurosurgery, and Psychiatry|April 5, 2011
ALS: disease or syndrome?Leonard H van den Berg
The Lancet. Neurology|May 20, 2017
Edaravone: a new treatment for ALS on the horizon?Orla Hardiman, Leonard H van den Berg
The Lancet. Neurology|January 24, 2006
Evidence-based care in amyotrophic lateral sclerosisSanne Piepers, Leonard H van den Berg
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|May 4, 2010
No benefits from experimental treatment with olfactory ensheathing cells in patients with ALSSanne Piepers, Leonard H van den Berg
The New England Journal of Medicine|July 9, 2020
The Beginning of Genomic Therapies for ALSOrla Hardiman, Leonard H van den Berg
Nature Genetics|September 30, 2009
Alzheimer's disease beyond APOEMichael A van Es, Leonard H van den Berg
Neurology|November 9, 2005
A way out of the maze: Campylobacter jejuni gene polymorphisms define Guillain-Barré syndromeJohn H J Wokke, Leonard H van den Berg
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 12, 2019
In pursuit of the normal progressor: the holy grail for ALS clinical trial design?Ruben P A van Eijk, Leonard H van Den Berg
Nature Reviews. Neurology|December 17, 2016
Gene discovery in amyotrophic lateral sclerosis: implications for clinical managementAmmar Al-Chalabi, Leonard H van den Berg, Jan Veldink
Pageof 56

Showing results (1-10 of 559) with videos related to

Sort By:
Pageof 56
The Lancet. Neurology|October 10, 2014
Therapy of amyotrophic lateral sclerosis remains a challengeLeonard H van den Berg
Journal of Neurology, Neurosurgery, and Psychiatry|April 5, 2011
ALS: disease or syndrome?Leonard H van den Berg
The Lancet. Neurology|May 20, 2017
Edaravone: a new treatment for ALS on the horizon?Orla Hardiman, Leonard H van den Berg
The Lancet. Neurology|January 24, 2006
Evidence-based care in amyotrophic lateral sclerosisSanne Piepers, Leonard H van den Berg
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|May 4, 2010
No benefits from experimental treatment with olfactory ensheathing cells in patients with ALSSanne Piepers, Leonard H van den Berg
The New England Journal of Medicine|July 9, 2020
The Beginning of Genomic Therapies for ALSOrla Hardiman, Leonard H van den Berg
Nature Genetics|September 30, 2009
Alzheimer's disease beyond APOEMichael A van Es, Leonard H van den Berg
Neurology|November 9, 2005
A way out of the maze: Campylobacter jejuni gene polymorphisms define Guillain-Barré syndromeJohn H J Wokke, Leonard H van den Berg
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 12, 2019
In pursuit of the normal progressor: the holy grail for ALS clinical trial design?Ruben P A van Eijk, Leonard H van Den Berg
Nature Reviews. Neurology|December 17, 2016
Gene discovery in amyotrophic lateral sclerosis: implications for clinical managementAmmar Al-Chalabi, Leonard H van den Berg, Jan Veldink
Pageof 56